http://web.archive.org/web/20130117132334id_/http://www.cnn.com/2012/01/09/health/drug-mix-up-fda/index.html

-- machinery problems at a drug manufacturing plant prompted the @entity3 to warn patients of a possible mix - up affecting various prescription pain medications and over-the - counter drugs			1
the @entity3 is advising patients who use certain prescription medications produced by @entity10 to visually inspect their pills			1
and consumers who have select bottles of @entity14 , @entity15 , @entity16 and @entity17 , produced by @entity18 , are being told to discard or return the products in a voluntary recall that started sunday			1
the over-the - counter drugs involved in the recall were manufactured at a @entity24 , @entity25 , facility which also produced various prescription pain medicines for @entity10 , according to the @entity3			1
these pills include @entity28 , @entity29 and @entity30			1
" due to problems that occurred when these products were packaged and labeled at the site , it 's possible that tablets from one product may have been retained in the packaging machinery and then may have carried over into the packaging of another product , " said dr. @entity31 , director of the @entity32 , @entity33 , @entity34 for the @entity3			2
" this could result in an incorrect pill ending up in the bottle of another product			0
the likelihood of this occurring in medication dispensed in patients is estimated to be low , " he added			0
the prescription opioids could have ended up in the bottle of another prescription drug or over-the - counter products , although " the risk of pills ending up in the wrong bottle is a rare event , " according to the @entity3			1
there have been no reports of adverse events due to this problem , @entity31 said			0
patients who take an affected @entity10 products should visually inspect all the pills in their bottles , according to the company and @entity3			1
@entity10 posted pictures of the products on their web page for tablet identifications			1
the products listed there : @entity29 ( oxymorphone hydrochloride ) extended - release tablets @entity76 ; @entity29 ( oxymorphone hydrochloride ) tablets @entity76 ; oxymorphone hydrochloride tablets @entity76 ; @entity28 ( oxycodone hydrochloride and acetaminophen @entity81 ) tablets @entity76 ; @entity30 ( oxycodone hydrochloride and aspirin , @entity81 ) tablets @entity76 ; @entity28 ( oxycodone hydrochloride and acetaminophen @entity81 ) tablets @entity76 ; @entity85 ( oxycodone hydrochloride and aspirin , @entity81 ) tablets @entity76 ; morphine sulfate extended - release tablets @entity76 ; and @entity91 ( hydrocodone bitartrate / acetaminophen tablets , @entity81 ) @entity89			2
" we are asking patients to check their medicines , to look for any tablets of a different size , shape or color from their regular medicine , " @entity31 said			0
" if they find any tablets that are different , stop taking the pain medication and take the medicine to the pharmacy			0
we are telling patients to look carefully at all tablets in pain medication bottle			0
" patients who have questions should contact @entity10 or their doctors , he advised			1
pharmacists are also being asked to " visually inspect and verify the identity of all tablets dispensed , " @entity31 said			2
" the likelihood of finding a wrong pill in an opioid pain medication is low , " he said			0
" patients should not be alarmed			0
these steps we 're recommending are additional steps we are recommending to further reduce an already low likelihood of medication mix - up			2
" the @entity25 plant has been temporarily shut down , which could cause drug shortages and disruptions in the supply chain for @entity10			1
" we anticipate that there may be a short - term disruption in the supply of these products to patients			2
this temporary supply disruption is not related to the efficacy or safety of these products , " according to the company			0
" we are not aware of any patient having experienced a confirmed product mix - up and there have been no adverse events attributable to a product mix - up			2
we believe the likelihood of product mix - up reaching a patient is remote , " according to the company			0
the over-the - counter items involved in the @entity18 recall include @entity14 and @entity16 products with expiration dates of december 20 , 2014 , or earlier , as well as @entity15 and @entity17 products with december 20 , 2013 , or earlier expiration dates			1
@entity18 had suspended operations at , and shipments from , the @entity24 , @entity25 , facility			1
the company said this was done " to accelerate maintenance " and make other improvements , adding that it currently " is not possible " to determine when the plant will reopen			0
consumers who have the affected products can contact @entity159 or try to obtain a refund .			0

machine problems could have mixed up *painkillers* and over-the - counter drugs
@entity18 issued a voluntary recall sunday for @entity14 , @entity15 , @entity16 , @entity17
*people* using @entity10 urged to inspect their pills

@entity17:Gas-X
@entity24:Lincoln
@entity25:Nebraska
@entity28:Endocet
@entity29:Opana
@entity15:Bufferin
@entity81:USP
@entity159:Novartis Consumer Relationship Center
@entity14:Excedrin
@entity85:Endodan
@entity89:CIII
@entity3:FDA
@entity0:CNN
@entity76:CII
@entity31:Cox
@entity30:Percodan
@entity33:Office of New Drugs
@entity32:Office of Antimicrobial Products
@entity34:Center for Drug Evaluation of Research
@entity10:Endo Pharmaceuticals
@entity18:Novartis
@entity91:Zydone
@entity16:NoDoz